Clinical Trial

Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke

Study acronym: NUVISTA2
Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized open-label, with blinded outcome pilot study to evaluate the effect on inflammatory and brain injury laboratory values and explore clinical outcomes in patients who present with ischemic strokes due to large vessel occlusions and are treated with either current accepted management, or accepted management in addition to transcutaneous auricular vagal nerve stimulation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-02-04; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Recruiting 2026-02-26
Trial Details
NCT Number NCT07404852
Lead Sponsor Washington University School of Medicine
Conditions Large Vessel Occlusion, Acute Ischemic Stroke
Enrollment 65 participants
Start Date 2026-02-23
Primary Completion 2027-11-29 (estimated)
Study Completion 2028-02-29 (estimated)
Updated on ClinicalTrials.gov 2026-04-13